You are here

Biblio

Author [ Title(Desc)] Type Year
Filters: Keyword is Aged  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Crane PK, Foroud T, Montine TJ, Larson EB.  2017.  Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.. Alzheimers Dement. 13(12):1410-1413.
Deters KD, Napolioni V, Sperling RA, Greicius MD, Mayeux R, Hohman T, Mormino EC.  2021.  Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.. Neurology. 96(11):e1491-e1500.
Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al..  2017.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.
Rajabli F, Feliciano BE, Celis K, Hamilton-Nelson KL, Whitehead PL, Adams LD, Bussies PL, Manrique CP, Rodriguez A, Rodriguez V et al..  2018.  Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.. PLoS Genet. 14(12):e1007791.
Granot-Hershkovitz E, Tarraf W, Kurniansyah N, Daviglus M, Isasi CR, Kaplan R, Lamar M, Perreira KM, Wassertheil-Smoller S, Stickel A et al..  2021.  APOE alleles' association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL).. Alzheimers Dement. 17(3):466-474.
Kulminski AM, Barochia AV, Loika Y, Raghavachari N, Arbeev KG, Wojczynski MK, Thyagarajan B, Vardarajan BN, Christensen K, Yashin AI et al..  2018.  The APOE ε4 allele is associated with a reduction in FEV1/FVC in women: A cross-sectional analysis of the Long Life Family Study.. PLoS One. 13(11):e0206873.
Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD et al..  2020.  Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.. JAMA Neurol. 77(10):1288-1298.
Smith JA, Zhao W, Yu M, Rumfelt KE, Moorjani P, Ganna A, Dey AB, Lee J, Kardia SLR.  2020.  Association Between Episodic Memory and Genetic Risk Factors for Alzheimer's Disease in South Asians from the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (LASI-DAD).. J Am Geriatr Soc. 68 Suppl 3:S45-S53.
Tynkkynen J, Chouraki V, van der Lee SJ, Hernesniemi J, Yang Q, Li S, Beiser A, Larson MG, Sääksjärvi K, Shipley MJ et al..  2018.  Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.. Alzheimers Dement. 14(6):723-733.
Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD.  2020.  Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.. JAMA Neurol. 77(7):849-862.
Rizvi B, Lao PJ, Chesebro AG, Dworkin JD, Amarante E, Beato JM, Gutierrez J, Zahodne LB, Schupf N, Manly JJ et al..  2021.  Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.. JAMA Netw Open. 4(10):e2125166.
Blue EE, Cheng A, Chen S, Yu C-E.  2020.  Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.. JAMA Netw Open. 3(10):e2017666.
Mishra A, Chauhan G, Violleau M-H, Vojinovic D, Jian X, Bis JC, Li S, Saba Y, Grenier-Boley B, Yang Q et al..  2019.  Association of variants in HTRA1 and NOTCH3 with MRI-defined extremes of cerebral small vessel disease in older subjects.. Brain. 142(4):1009-1023.
Walker JM, Fudym Y, Farrell K, Iida MA, Bieniek KF, Seshadri S, White CL, Crary JF, Richardson TE.  2021.  Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease.. J Neuropathol Exp Neurol. 80(5):436-445.
C
Peloso GM, Beiser AS, Satizabal CL, Xanthakis V, Vasan RS, Pase MP, DeStefano AL, Seshadri S.  2020.  Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study.. Neurology. 95(10):e1341-e1350.
Andrews SJ, Fulton-Howard B, O'Reilly P, Marcora E, Goate AM.  2021.  Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome.. Ann Neurol. 89(1):54-65.
Kling MA, Goodenowe DB, Senanayake V, MahmoudianDehkordi S, Arnold M, Massaro TJ, Baillie R, Han X, Leung Y-Y, Saykin AJ et al..  2020.  Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.. Alzheimers Dement. 16(9):1234-1247.
McGrath ER, Himali JJ, Levy D, Conner SC, Pase MP, Abraham CR, Courchesne P, Satizabal CL, Vasan RS, Beiser AS et al..  2019.  Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.. PLoS One. 14(3):e0213321.
Wang L, Qiao Y, Zhang H, Zhang Y, Hua J, Jin S, Liu G.  2020.  Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank.. J Alzheimers Dis. 73(2):609-618.
Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, Yanek LR, Wen W, Gudnason VG, Dueker ND et al..  2020.  Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.. Stroke. 51(7):2111-2121.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I et al..  2021.  Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.. Nat Commun. 12(1):3417.
Srinivasan D, Erus G, Doshi J, Wolk DA, Shou H, Habes M, Davatzikos C.  2020.  A comparison of Freesurfer and multi-atlas MUSE for brain anatomy segmentation: Findings about size and age bias, and inter-scanner stability in multi-site aging studies.. Neuroimage. 223:117248.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer